Brief: Kaly Confirms Consolidation Plans To Focus On $50 Bln Cannabis Biopharmaceutical Market Opportunity
15/01/2020 13:05
Jan 15 (Reuters) - Kali Inc KALY.PK :
* KALY CONFIRMS CONSOLIDATION PLANS TO FOCUS ON $50 BILLION
CANNABIS BIOPHARMACEUTICAL MARKET OPPORTUNITY
Source text for Eikon: ID:nPn3Q3Qz2a
Further company coverage: KALY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kali
See all newsBrief: KALY-Kali-Extracts RespRx Could Offer Treatment For Coronavirus Symptoms
Brief: Pura Explores Acquisition Of Kaly CBD Confection Assets
Brief: Kaly Confirms Consolidation Plans To Focus On $50 Bln Cannabis Biopharmaceutical Market Opportunity
Brief: Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements
Brief: Kali Says Co Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements